3 Questions: Cullen Buie on a new era for cell therapies
The associate professor of MechE reflects on how his company, Kytopen, has grown and shifted focus in developing safer immunotherapies.
The associate professor of MechE reflects on how his company, Kytopen, has grown and shifted focus in developing safer immunotherapies.
Startups founded by mechanical engineers are at the forefront of developing solutions to mitigate the environmental impact of manufacturing.
A program within MIT Corporate Relations has become the largest university-based platform for startups to connect with corporations.
Chandrakasan honored for his “contributions to ultralow-power circuits and systems, and leadership in academia and advancing diversity in the profession.”
MIT spinoff Via Separations aims for industrial decarbonization with its durable graphene oxide membranes.
Kytopen is speeding up both discovery and delivery of engineered cell therapies with its transformative Flowfect platforms.
At MIT Forefront, industry and Institute leaders discuss how businesses play a pivotal role in deploying new technologies that will mitigate climate change.
PhD student and 2017 J-WAFS graduate fellow Tzu-Chieh Tang designs living materials to solve environmental challenges, with an emphasis on safety and scalability.
MIT spinout continues its investment in early-stage startups working to solve key challenges in climate change, human health, and advanced systems.
Cambridge Crops develops an edible, imperceptible coating that might replace plastic packaging to preserve meats and produce.
MIT’s vice president for research identifies three areas that show particular promise for climate action.
New location will support growing innovation ecosystem; serve as hub for the region.
MIT spinoff is changing the way mosquito-borne illnesses are diagnosed and aims to influence how public health officials react to disease outbreaks.
MIT Energy Initiative Director Robert Armstrong offers his perspective on the takeaways from MITEI’s annual research conference.